Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding operating status notice from the page; this does not impact the study information presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe screenshots show only minor visual differences and no changes to essential study details like eligibility, outcomes, enrollment status, or study locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference4%

- Check69 days agoChange DetectedVersion bump to v3.1.0 with removal of several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a reorganization or narrowing of content.SummaryDifference0.5%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The Back to Top element was removed; no substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.